Microsoft: A Critical Point in Valuation Momentum
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
Mesoblast (MESO) stock forecast for 2026
Updated: May 24, 2025 (02:03)
Sector: HealthcareThe share price of Mesoblast Limited (MESO) now
50/200 Day Moving Average: $11.78 / $11.84
This figure corresponds to the Average Price over the previous 50/200 days. For Mesoblast stocks, the 50-day moving average is the resistance level today.
For Mesoblast stocks, the 200-day moving average is the resistance level today.
Are you interested in Mesoblast Limited stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Mesoblast stock price in 2026. How much will one Mesoblast share be worth in 2026? Is it worth taking profit / loss on MESO stock now or waiting? What are analysts' forecasts for Mesoblast stock?
We forecast Mesoblast stock performance using neural networks based on historical data on MESO stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Mesoblast Limited stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Mesoblast analysts is $27. Today 200 Day Moving Average is the support level (11.84 $). 50 Day Moving Average is the support level (11.78 $).
Historical and forecast chart of Mesoblast Limited stock
The chart below shows the historical price of Mesoblast stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the MESO stock price can be found in the table below.
The biopharmaceutical company Mesoblast Limited develops and markets allogeneic cellular medicines. The company offers products for the treatment of cardiovascular diseases, orthopedic diseases of the spine, oncology, hematology, as well as for immune-mediated and inflammatory diseases. Its patented regenerative medicine technology platform is based on specialized cells known as adult stem cells of mesenchymal origin.
Mesoblast (MESO) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 12.32 | 11.47 | 12.66 | 9.35 % |
| Feb | 12.82 | 11.88 | 13.13 | 9.47 % |
| Mar | 14.07 | 13.68 | 14.43 | 5.17 % |
| Apr | 14.12 | 13.64 | 15.19 | 10.22 % |
| May | 13.93 | 13.63 | 14.66 | 7.03 % |
| Jun | 13.53 | 12.58 | 14.15 | 11.09 % |
| Jul | 14.39 | 13.62 | 14.80 | 7.98 % |
| Aug | 15.10 | 14.16 | 15.66 | 9.55 % |
| Sep | 14.86 | 13.82 | 16.05 | 13.89 % |
| Oct | 15.99 | 14.88 | 16.48 | 9.70 % |
| Nov | 15.57 | 15.12 | 15.90 | 4.90 % |
| Dec | 15.65 | 15.34 | 16.84 | 8.92 % |
Mesoblast information and performance
LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU
Market capitalization of the Mesoblast Limited is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MESO shares in the company outstanding by the market price of one share.
EBITDA of Mesoblast is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Mesoblast price target for 2026 by month
Target values for the price of one Mesoblast share for Jan 2026.
In Jan, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 9.348% volatility is expected.
Pessimistic target level: 11.47
Optimistic target level: 12.66
Target values for the price of one Mesoblast share for Feb 2026.
In Feb, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 9.473% volatility is expected.
Pessimistic target level: 11.88
Optimistic target level: 13.13
Target values for the price of one Mesoblast share for Mar 2026.
In Mar, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 5.171% volatility is expected.
Pessimistic target level: 13.68
Optimistic target level: 14.43
Target values for the price of one Mesoblast share for Apr 2026.
In Apr, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 10.223% volatility is expected.
Pessimistic target level: 13.64
Optimistic target level: 15.19
Target values for the price of one Mesoblast share for May 2026.
In May, the Negative dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 7.034% volatility is expected.
Pessimistic target level: 13.63
Optimistic target level: 14.66
Target values for the price of one Mesoblast share for Jun 2026.
In Jun, the Negative dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 11.090% volatility is expected.
Pessimistic target level: 12.58
Optimistic target level: 14.15
Target values for the price of one Mesoblast share for Jul 2026.
In Jul, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 7.976% volatility is expected.
Pessimistic target level: 13.62
Optimistic target level: 14.80
Target values for the price of one Mesoblast share for Aug 2026.
In Aug, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 9.547% volatility is expected.
Pessimistic target level: 14.16
Optimistic target level: 15.66
Target values for the price of one Mesoblast share for Sep 2026.
In Sep, the Negative dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 13.889% volatility is expected.
Pessimistic target level: 13.82
Optimistic target level: 16.05
Target values for the price of one Mesoblast share for Oct 2026.
In Oct, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 9.699% volatility is expected.
Pessimistic target level: 14.88
Optimistic target level: 16.48
Target values for the price of one Mesoblast share for Nov 2026.
In Nov, the Negative dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 4.897% volatility is expected.
Pessimistic target level: 15.12
Optimistic target level: 15.90
Target values for the price of one Mesoblast share for Dec 2026.
In Dec, the Positive dynamics for Mesoblast Limited shares will prevail with possible monthly volatility of 8.922% volatility is expected.
Pessimistic target level: 15.34
Optimistic target level: 16.84
